Showing results (1321-1330 of 1,753) with videos related to
Sort By:
Pageof 176
Physiological Reports|August 4, 2022
Efficacy of leupeptin in treating ischemia in a rat hind limb modelMikhail Gurevich, Kari Iocolano, Irene Nozal Martin, et al.Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 16, 2019
[Medical rehabilitation of patients with alcohol dependency at risk of parental rights deprivation]T V Agibalova, I I Akhmetzyanov, R F Khaeva, et al.Advances in Therapy|March 5, 2022
Long-Term Persistence and Monotherapy with Device-Aided Therapies: A Retrospective Analysis of an Israeli Cohort of Patients with Advanced Parkinson's DiseaseAvner Thaler, Yael Barer, Ruth Gross, et al.Physical Review Letters|September 7, 2019
Third Order Dispersion in Time-Delayed SystemsC Schelte, P Camelin, M Marconi, et al.Arkhiv Patologii|June 24, 2011
[Coupling between the hemodynamic parameters and the morphological changes in the kidney in children with congenital hydronephrosis]L O Severgina, L V Leonova, E S Severgina, et al.Medical Care|October 8, 2011
Administrative hospitalization database validation of cardiac procedure codesDouglas S Lee, Audra Stitt, Xuesong Wang, et al.The Journal of Biological Chemistry|February 28, 2002
Aspartic acid 564 in the third cytoplasmic loop of the luteinizing hormone/choriogonadotropin receptor is crucial for phosphorylation-independent interaction with arrestin2Sutapa Mukherjee, Vsevolod V Gurevich, Anita Preninger, et al.American Journal of Medical Genetics|January 16, 1995
Trisomy 2p: analysis of unusual phenotypic findingsI W Lurie, H G Ilyina, D B Gurevich, et al.Infection and Immunity|July 1, 1997
Mycoplasma synoviae has two distinct phase-variable major membrane antigens, one of which is a putative hemagglutininA H Noormohammadi, P F Markham, K G Whithear, et al.Terapevticheskii Arkhiv|November 12, 2005
[Low ability of blood lymphocytes to produce interferon-gamma in patients with idiopathic prolapse of mitral valve]I D Surkina, K G Gurevich, O O Mel'nik, et al.Pageof 176